Huang, De
Wang, Yan http://orcid.org/0000-0002-8150-5486
Thompson, J. Will
Yin, Tao
Alexander, Peter B.
Qin, Diyuan
Mudgal, Poorva
Wu, Haiyang
Liang, Yaosi http://orcid.org/0000-0002-3478-0864
Tan, Lianmei
Pan, Christopher
Yuan, Lifeng http://orcid.org/0000-0002-5367-7512
Wan, Ying
Li, Qi-Jing http://orcid.org/0000-0002-0542-9784
Wang, Xiao-Fan http://orcid.org/0000-0001-7875-3940
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 7 April 2021
Accepted: 23 November 2021
First Online: 10 February 2022
Competing interests
: Q.-J.L. is a scientific co-founder and shareholder of TCRCure Biopharma. The remaining authors declare no competing interests.